Total Payments
$597,464
2024 Payments
$20,869
Companies
36
Transactions
975
Medicare Patients
816
Medicare Billing
$123,485
Payment Breakdown by Category
Other$438,621 (73.4%)
Consulting$108,926 (18.2%)
Travel$27,294 (4.6%)
Food & Beverage$21,937 (3.7%)
Education$685.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $437,721 | 172 | 73.3% |
| Consulting Fee | $108,926 | 33 | 18.2% |
| Travel and Lodging | $27,294 | 108 | 4.6% |
| Food and Beverage | $21,937 | 649 | 3.7% |
| Honoraria | $900.00 | 1 | 0.2% |
| Education | $685.90 | 12 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $148,319 | 141 | $0 (2023) |
| GENZYME CORPORATION | $126,553 | 148 | $0 (2024) |
| EMD Serono, Inc. | $110,394 | 166 | $0 (2024) |
| Genentech USA, Inc. | $49,019 | 54 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $46,166 | 64 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $45,686 | 210 | $0 (2022) |
| Celgene Corporation | $27,519 | 60 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $19,716 | 11 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $10,555 | 14 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $4,236 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,869 | 61 | EMD Serono, Inc. ($12,778) |
| 2023 | $29,678 | 61 | EMD Serono, Inc. ($25,196) |
| 2022 | $87,698 | 132 | Biogen, Inc. ($34,313) |
| 2021 | $65,407 | 115 | Biogen, Inc. ($21,182) |
| 2020 | $69,127 | 114 | Biogen, Inc. ($35,386) |
| 2019 | $70,634 | 161 | Biogen, Inc. ($19,205) |
| 2018 | $108,372 | 143 | GENZYME CORPORATION ($24,159) |
| 2017 | $145,679 | 188 | GENZYME CORPORATION ($65,898) |
All Payment Transactions
975 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.56 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| 12/04/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Immunology | ||||||
| 12/03/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 12/02/2024 | Genentech, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $31.85 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Rare Disease | ||||||
| 11/08/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $3.89 | General |
| 10/30/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/28/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,050.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/28/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | Cash or cash equivalent | $124.97 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/21/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Neuroscience | ||||||
| 10/16/2024 | Alexion Pharmaceuticals, Inc. | — | Education | In-kind items and services | $100.00 | General |
| 10/08/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 09/25/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| 08/22/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/09/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/05/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $82.57 | General |
| 07/31/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/26/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,243.00 | General |
| Category: Neurology | ||||||
| 07/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 204 | 285 | $80,807 | $32,477 |
| 2022 | 2 | 203 | 267 | $72,913 | $31,084 |
| 2021 | 4 | 211 | 275 | $76,033 | $32,223 |
| 2020 | 4 | 198 | 280 | $72,336 | $27,702 |
Total Patients
816
Total Services
1,107
Medicare Billing
$123,485
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 169 | 242 | $71,390 | $28,648 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 43 | $9,417 | $3,829 | 40.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 161 | 224 | $63,840 | $27,402 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 43 | $9,073 | $3,682 | 40.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 151 | 212 | $58,512 | $25,759 | 44.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $9,062 | $3,066 | 33.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 27 | $5,508 | $2,542 | 46.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 13 | $2,951 | $855.90 | 29.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 122 | 194 | $51,798 | $19,704 | 38.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 45 | 53 | $10,494 | $3,998 | 38.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 19 | 19 | $7,258 | $2,852 | 39.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 12 | 14 | $2,786 | $1,149 | 41.2% |
About Dr. Barbara Green, MD
Dr. Barbara Green, MD is a Neurology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497783997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Green, MD has received a total of $597,464 in payments from pharmaceutical and medical device companies, with $20,869 received in 2024. These payments were reported across 975 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($437,721).
As a Medicare-enrolled provider, Green has provided services to 816 Medicare beneficiaries, totaling 1,107 services with total Medicare billing of $123,485. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Saint Louis, MO
- Active Since 06/30/2006
- Last Updated 02/19/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1497783997
Products in Payments
- AUBAGIO (Drug) $92,469
- TYSABRI (Biological) $48,644
- Mavenclad (Drug) $48,116
- COPAXONE (Drug) $44,047
- GILENYA (Drug) $43,735
- ZEPOSIA (Drug) $36,701
- OCREVUS (Biological) $32,827
- TECFIDERA (Drug) $29,790
- MAVENCLAD (Drug) $24,865
- LEMTRADA (Drug) $24,638
- VUMERITY (Drug) $24,119
- Mavenclad (Biological) $20,761
- Non-Covered Product (Drug) $13,378
- Ponvory (Drug) $8,004
- Ozanimod (Drug) $7,977
- Rebif (Biological) $6,728
- DISEASE STATE (Drug) $6,248
- PONVORY (Drug) $4,236
- Ocrevus (Biological) $2,842
- AJOVY (Drug) $2,120
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Saint Louis
Barry Singer
Neurology — Payments: $2.7M
Neurology $2.7M
Dr. Mark Tullman, M.d, M.D
Neurology — Payments: $2.1M
Neurology $2.1M
Dr. Robert Naismith, Md, MD
Neurology — Payments: $774,163
Neurology $774,163
Dr. Arun Varadhachary, Md, MD
Neurology — Payments: $373,665
Neurology $373,665
Dr. Anne Cross, Md, MD
Neurology — Payments: $270,789
Neurology $270,789
Pratap Chand, Md, MD
Neurology — Payments: $210,058
Neurology $210,058